Security key
92532F100
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX)
CUSIP: 92532F100
Q2 2017 13F Holders as of 30 Jun 2017
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 236,016,217
- Total 13F value
- $30,400,623,804
- Share change
- +406,711
- Put/Call ratio
- 36%
- SEC-reported price per share
- $128.87
- Number of holders
- 569
- Value change
- +$78,079,742
- Number of buys
- 303
- Number of sells
- 216
- Shares outstanding
- 254,406,089
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2017
Institutions
569
Top holders
10
VRTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2017
Previous quarter: Q1 2017
VERTEX PHARMACEUTICALS INC / MA SEC filings
VERTEX PHARMACEUTICALS INC / MA company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92532F100
Recent filing periods:
Ownership snapshot
Top reported holders of VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
PRICE T ROWE ASSOCIATES I...
Disclosed value leader
PRICE T ROWE ASSOCIATES I...
Comparable rows
15/15
Latest evidence
31 Mar 2017
13F
Lead comparable stake: 9%
Showing 1-6 of 15 holder rows.
Quick read
PRICE T ROWE ASSOCIATES INC /MD/ leads the comparable SEC ownership view at 9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens PRICE T ROWE ASSOCIATES INC /MD/'s linked filing trail.
Comparable ownership
Top 5
PRICE T ROWE ASSOCIATES INC /MD/
9%
BlackRock Finance, Inc.
7.6%
FMR LLC
7.4%
Capital World Investors
7%
WELLINGTON MANAGEMENT GROUP LLP
7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
9%
|
$2,512,715,000
22,978,643 shares
|
— | 31 Mar 2017 |
| BlackRock Finance, Inc. |
13F
Company
|
7.6%
|
$2,104,591,000
19,246,380 shares
|
— | 31 Mar 2017 |
| FMR LLC |
13F
Company
|
7.4%
|
$2,062,849,000
18,864,648 shares
|
— | 31 Mar 2017 |
| Capital World Investors |
13F
Company
|
7%
|
$1,957,467,000
17,900,933 shares
|
— | 31 Mar 2017 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
7%
|
$1,942,704,000
17,765,933 shares
|
— | 31 Mar 2017 |
| VANGUARD GROUP INC |
13F
Company
|
6.5%
|
$1,801,530,000
16,474,890 shares
|
— | 31 Mar 2017 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2017
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
569
Shares
236,016,217
Rows available
569
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2017 vs Q1 2017 Across Filers
Q1 2017 holders
512
Q2 2017 holders
569
Holder diff
57
| Investor | Q1 2017 Shares | Q2 2017 Shares | Share Diff | Share Chg % | Q1 2017 value | Q2 2017 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend